combretastatin has been researched along with fluorescein-5-isothiocyanate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hori, K; Nishihara, M; Shiraishi, K; Yokoyama, M | 1 |
1 other study(ies) available for combretastatin and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
The combretastatin derivative (Cderiv), a vascular disrupting agent, enables polymeric nanomicelles to accumulate in microtumors.
Topics: Animals; Antineoplastic Agents; Bibenzyls; Blood Vessels; Fluorescein; Fluorescein-5-isothiocyanate; Hemodynamics; Male; Neoplasms; Oxides; Polymers; Rats; Serum Albumin | 2010 |